Literature DB >> 28913446

Effects of a novel cytokine haemoadsorbtion system on inflammatory response in septic shock after cephalic pancreatectomy - a case report.

Dana Tomescu1,2, Simona O Dima3, Sabina Tănăsescu1, Cristiana Pistol Tănase4, Anca Năstase3, Mihai Popescu2.   

Abstract

Severe sepsis and septic shock are associated with an inflammatory cascade that is primarily responsible for multiple organ dysfunction. To date, there are no specific treatments designed to modulate and rebalance inflammatory cytokines levels. We present a case of a 50 years old man with postoperative septic shock after undergoing cephalic pancreatectomy for a pancreatic cystic tumor. The use of a haemoadsorbtion device (CytoSorb®) in combination with continuous veno-venous haemofiltration was associated with a decrease in TNFα, IL-1β and IFNγ and an increase in IL-10 levels measured before and after two consecutive procedures. The effect of CytoSorb® on inflammatory cytokines translated into a more stable haemodynamic profile with a stable cardiac output and normalization of systemic vascular resistance index and decreased vasopressor requirements. Further prospective large clinical trials are required in order to determine the indications for CytoSorb® and to evaluate the overall outcome.

Entities:  

Keywords:  CytoSorb; cytokines; haemodynamics; haemofiltration; inflammation; pancreatectomy; sepsis; xMAP assay

Year:  2014        PMID: 28913446      PMCID: PMC5505352     

Source DB:  PubMed          Journal:  Rom J Anaesth Intensive Care        ISSN: 2392-7518


  13 in total

1.  Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective.

Authors:  Laura J Moore; Frederick A Moore; S Rob Todd; Stephen L Jones; Krista L Turner; Barbara L Bass
Journal:  Arch Surg       Date:  2010-07

2.  Improvement of hemodynamic and inflammatory parameters by combined hemoadsorption and hemodiafiltration in septic shock: a case report.

Authors:  Steffen R Mitzner; Martin Gloger; Jörg Henschel; Sebastian Koball
Journal:  Blood Purif       Date:  2013-07-31       Impact factor: 2.614

Review 3.  Sepsis syndromes: understanding the role of innate and acquired immunity.

Authors:  A Oberholzer; C Oberholzer; L L Moldawer
Journal:  Shock       Date:  2001-08       Impact factor: 3.454

4.  Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.

Authors:  P Heering; S Morgera; F J Schmitz; G Schmitz; R Willers; H P Schultheiss; B E Strauer; B Grabensee
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

5.  Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy.

Authors:  Hubert Hetz; Reinhard Berger; Peter Recknagel; Heinz Steltzer
Journal:  Int J Artif Organs       Date:  2014-04-17       Impact factor: 1.595

6.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

7.  Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.

Authors:  D A Zisman; S L Kunkel; R M Strieter; J Gauldie; W C Tsai; J Bramson; J M Wilkowski; K A Bucknell; T J Standiford
Journal:  Shock       Date:  1997-11       Impact factor: 3.454

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

Review 9.  Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.

Authors:  Fabienne Venet; Anne-Claire Lukaszewicz; Didier Payen; Richard Hotchkiss; Guillaume Monneret
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

10.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Authors:  E Abraham; R Wunderink; H Silverman; T M Perl; S Nasraway; H Levy; R Bone; R P Wenzel; R Balk; R Allred
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272

View more
  1 in total

1.  Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient.

Authors:  Marianne Alarie; Maggie Savelberg; Danika Vautour; Igo B Ribeiro
Journal:  J Cardiothorac Surg       Date:  2022-07-07       Impact factor: 1.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.